Chronic thromboembolic pulmonary hypertension is a debilitating disease requiring prompt diagnosis, lifetime anticoagulation, and pulmonary endarterectomy for effective treatment.
Highlights importance of surgical referral in CTEPH; leaves open evidence gaps for filters and anticoagulation duration.
Chronic thromboembolic pulmonary hypertension with cor pulmonale is an extremely debilitating disease that (1) is more common than generally recognized, (2) is often misdiagnosed, and (3) is difficult to treat. When a patient has persistent exertional dyspnea with no obvious cause, a ventilation-perfusion scan, echocardiography, and (if indicated) pulmonary angiography should be done. Prevention is especially important because by the time a patient is symptomatic, the disease is already far advanced and hemodynamic reserves are greatly reduced. Prevention of recurrence mandates lifetime anticoagulation and placement of a vena cava filter. The only effective treatment is pulmonary endarterectomy, which is being performed at an increasing number of specialty centers across the United States.
No takes yet. Share an insight, caveat, or question.
Feied et al. (1995) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: